Can Mark Cuban’s Low-Price Drug Firm Disrupt the Pharma Business? | WSJ

Drug costs stay out of attain for a lot of People, who pay among the many highest costs on the earth. In an interview with WSJ, billionaire investor Mark Cuban explains how his low-cost, on-line drug firm works and the challenges it faces in a consolidated trade. Photograph illustration: Adele Morgan/Storyblocks

Extra from the Wall Avenue Journal:
Go to
Go to the WSJ Video Middle:

On Fb:
On Twitter:
On Snapchat:

#MarkCuban #Pharma #WSJ


Wall Street Journal

Leave a Reply

Your email address will not be published. Required fields are marked *